TrialJournal of thrombosis and thrombolysis2009

Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.

Alexey A Mazaev et al.PubMed ↗Publisher ↗

No numbers read from the abstract.